These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 11524591)

  • 1. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
    Ghobrial RM; Steadman R; Gornbein J; Lassman C; Holt CD; Chen P; Farmer DG; Yersiz H; Danino N; Collisson E; Baquarizo A; Han SS; Saab S; Goldstein LI; Donovan JA; Esrason K; Busuttil RW
    Ann Surg; 2001 Sep; 234(3):384-93; discussion 393-4. PubMed ID: 11524591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant model to predict posttransplant survival in liver transplant patients.
    Ghobrial RM; Gornbein J; Steadman R; Danino N; Markmann JF; Holt C; Anselmo D; Amersi F; Chen P; Farmer DG; Han S; Derazo F; Saab S; Goldstein LI; McDiarmid SV; Busuttil RW
    Ann Surg; 2002 Sep; 236(3):315-22; discussion 322-3. PubMed ID: 12192318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
    Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
    Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New era of liver transplantation for hepatitis B: a 17-year single-center experience.
    Anselmo DM; Ghobrial RM; Jung LC; Weaver M; Cao C; Saab S; Kunder G; Chen PW; Farmer DG; Yersiz H; Baquerizo A; Geevarghese S; Han SH; Goldstein L; Holt CD; Gornbein JA; Busuttil RW
    Ann Surg; 2002 May; 235(5):611-9; discussion 619-20. PubMed ID: 11981206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nonviral factors on hepatitis C recurrence after liver transplantation.
    Cameron AM; Ghobrial RM; Hiatt JR; Carmody IC; Gordon SA; Farmer DG; Yersiz H; Zimmerman MA; Durazo F; Han SH; Saab S; Gornbein J; Busuttil RW
    Ann Surg; 2006 Oct; 244(4):563-71. PubMed ID: 16998365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients.
    Velidedeoglu E; Mange KC; Frank A; Abt P; Desai NM; Markmann JW; Reddy R; Markmann JF
    Transplantation; 2004 Jun; 77(12):1834-42. PubMed ID: 15223900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome of liver grafts procured from hepatitis C-positive donors.
    Velidedeoglu E; Desai NM; Campos L; Olthoff KM; Shaked A; Nunes F; Zeldin G; Stewart C; Blumberg E; Abrams J; Markmann JF
    Transplantation; 2002 Feb; 73(4):582-7. PubMed ID: 11889435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors in liver retransplantation: a single-center experience.
    Crivellin C; De Martin E; Germani G; Gambato M; Senzolo M; Russo FP; Vitale A; Zanus G; Cillo U; Burra P
    Transplant Proc; 2011 May; 43(4):1110-3. PubMed ID: 21620065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P
    Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database.
    Burr AT; Li Y; Tseng JF; Saidi RF; Bozorgzadeh A; Shah SA
    World J Surg; 2011 Jul; 35(7):1590-5. PubMed ID: 21384242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retransplantation for late liver graft failure: predictors of mortality.
    Facciuto M; Heidt D; Guarrera J; Bodian CA; Miller CM; Emre S; Guy SR; Fishbein TM; Schwartz ME; Sheiner PA
    Liver Transpl; 2000 Mar; 6(2):174-9. PubMed ID: 10719016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of hepatitis C virus-positive grafts in liver transplantation: a single-centre experience.
    Ricchiuti A; Brunati A; Mirabella S; Pierini A; Franchello A; Salizzoni M
    Transplant Proc; 2005; 37(6):2569-70. PubMed ID: 16182746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity.
    Gayowski T; Marino IR; Singh N; Doyle H; Wagener M; Fung JJ; Starzl TE
    Transplantation; 1998 Feb; 65(4):499-504. PubMed ID: 9500623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation using donors older than 80 years: a single-center experience.
    Petridis I; Gruttadauria S; Nadalin S; Viganò J; di Francesco F; Pietrosi G; Fili' D; Montalbano M; D'Antoni A; Volpes R; Arcadipane A; Vizzini G; Gridelli B
    Transplant Proc; 2008; 40(6):1976-8. PubMed ID: 18675105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.